1. Treatment of patients with primary cutaneous lymphomas – real-life data
- Author
-
Ewa Chmielowska, Aleksandra Grzanka-Gadzińska, Michal Marjanski, Monika Olejniczak, Małgorzata Sokołowska-Wojdyło, Anna Krause, Karolina Wróblewska, and Maciej Studziński
- Subjects
Cancer Research ,Mycosis fungoides ,medicine.medical_specialty ,Heterogeneous group ,business.industry ,Dermatology department ,Disease ,medicine.disease ,Real life data ,Dermatology ,Cutaneous lymphoma ,Oncology ,Overall survival ,medicine ,Proper treatment ,business - Abstract
Background. Primary cutaneous lymphomas (PCL) comprise a heterogeneous group of neoplasms of mature lymphocytes with skin tropism. Although, by definition, these lymphomas are restricted to the skin at the time of diagnosis, during the course of the disease it may involve also lymph nodes and visceral organs. A close cooperation between a dermatologist and oncologist is required to ensure proper treatment. We present in a real-life data on treatment of patients with PCL between dermatology and oncology department. Material and methods. 104 patients were registered in a joined database of Oncology Department of Oncology Centre in Bydgoszcz and Dermatology Department of Medical University in Torun between 2007 and 2017. Due to different clinical and prognostic features data from MF/SS (44 patients), non-MF/SS CTCLs and CBCLs were presented separately. Results. Median overall survival for patients with MF/SS was 76.7 months. Median follow-up time was 5 years.
- Published
- 2019
- Full Text
- View/download PDF